| 0 |
INSULIN THERAPY |
1 |
0.0833 |
| 1 |
LEUKOCYTE VACUOLISATION |
1 |
0.0625 |
| 2 |
BLOOD FIBRINOGEN ABNORMAL |
1 |
0.0175 |
| 3 |
BASOPHILIA |
1 |
0.0133 |
| 4 |
LYMPHOCYTE COUNT ABNORMAL |
13 |
0.0115 |
| 5 |
YERSINIA INFECTION |
1 |
0.0098 |
| 6 |
CATHETER SITE DISCOLOURATION |
1 |
0.0082 |
| 7 |
NONINFECTIVE SIALOADENITIS |
1 |
0.0063 |
| 8 |
EPSTEIN-BARR VIRUS INFECTION REACTIVATION |
8 |
0.0061 |
| 9 |
POSTPRANDIAL HYPOGLYCAEMIA |
1 |
0.0053 |
| 10 |
SENSORY OVERLOAD |
1 |
0.0051 |
| 11 |
EPSTEIN-BARR VIRUS ANTIBODY POSITIVE |
2 |
0.0051 |
| 12 |
THROMBOPHLEBITIS SEPTIC |
1 |
0.0049 |
| 13 |
INFLUENZA VIRUS TEST POSITIVE |
1 |
0.0047 |
| 14 |
PRODUCT ADVERTISING ISSUE |
1 |
0.0047 |
| 15 |
INFLUENZA A VIRUS TEST POSITIVE |
2 |
0.0046 |
| 16 |
LYMPHOPENIA |
62 |
0.0044 |
| 17 |
ASPARTATE AMINOTRANSFERASE DECREASED |
2 |
0.0038 |
| 18 |
CATHETER SITE THROMBOSIS |
1 |
0.0036 |
| 19 |
DOSE CALCULATION ERROR |
2 |
0.0034 |
| 20 |
SERUM FERRITIN ABNORMAL |
1 |
0.0031 |
| 21 |
LYMPHOCYTE COUNT DECREASED |
55 |
0.0031 |
| 22 |
ACANTHOSIS |
1 |
0.0030 |
| 23 |
CUBITAL TUNNEL SYNDROME |
1 |
0.0029 |
| 24 |
INFUSION SITE RASH |
4 |
0.0029 |
| 25 |
GLASSY EYES |
2 |
0.0028 |
| 26 |
CORNEAL REFLEX DECREASED |
1 |
0.0027 |
| 27 |
CAPILLARY DISORDER |
1 |
0.0026 |
| 28 |
ARACHNOID CYST |
1 |
0.0025 |
| 29 |
OROPHARYNGEAL PLAQUE |
1 |
0.0025 |
| 30 |
INFUSION SITE SCAR |
1 |
0.0023 |
| 31 |
EYELID RASH |
2 |
0.0020 |
| 32 |
OVARIAN FAILURE |
1 |
0.0019 |
| 33 |
GASTROENTERITIS ESCHERICHIA COLI |
1 |
0.0018 |
| 34 |
LYMPHOCYTE MORPHOLOGY ABNORMAL |
1 |
0.0017 |
| 35 |
HYPOCHLORAEMIA |
2 |
0.0017 |
| 36 |
LYMPHATIC DISORDER |
1 |
0.0017 |
| 37 |
CATARACT SUBCAPSULAR |
1 |
0.0016 |
| 38 |
EPSTEIN-BARR VIRUS TEST POSITIVE |
1 |
0.0016 |
| 39 |
INFUSION SITE PRURITUS |
5 |
0.0016 |
| 40 |
INFUSION SITE IRRITATION |
2 |
0.0016 |
| 41 |
BLOOD LACTATE DEHYDROGENASE ABNORMAL |
1 |
0.0015 |
| 42 |
PROTHROMBIN TIME ABNORMAL |
1 |
0.0014 |
| 43 |
FACIAL DISCOMFORT |
1 |
0.0014 |
| 44 |
GENITAL RASH |
2 |
0.0014 |
| 45 |
PRODUCT DESIGN ISSUE |
1 |
0.0014 |
| 46 |
ALANINE AMINOTRANSFERASE DECREASED |
1 |
0.0014 |
| 47 |
AXILLARY PAIN |
2 |
0.0013 |
| 48 |
MICROALBUMINURIA |
1 |
0.0013 |
| 49 |
SKIN SWELLING |
11 |
0.0013 |
| 50 |
CYTOKINE RELEASE SYNDROME |
25 |
0.0012 |
| 51 |
KETONURIA |
1 |
0.0012 |
| 52 |
VEIN RUPTURE |
2 |
0.0012 |
| 53 |
SUPERFICIAL VEIN THROMBOSIS |
1 |
0.0012 |
| 54 |
PREMATURE MENOPAUSE |
1 |
0.0011 |
| 55 |
CATHETER SITE SWELLING |
1 |
0.0011 |
| 56 |
BLOOD ALKALINE PHOSPHATASE DECREASED |
1 |
0.0011 |
| 57 |
LIVER FUNCTION TEST INCREASED |
22 |
0.0010 |
| 58 |
DEVICE RELATED THROMBOSIS |
1 |
0.0010 |
| 59 |
INFUSION SITE BRUISING |
2 |
0.0009 |
| 60 |
PRODUCT NAME CONFUSION |
1 |
0.0009 |
| 61 |
PRODUCT SELECTION ERROR |
1 |
0.0009 |
| 62 |
INFECTIOUS MONONUCLEOSIS |
2 |
0.0009 |
| 63 |
PALMAR ERYTHEMA |
1 |
0.0009 |
| 64 |
PHYSICAL PRODUCT LABEL ISSUE |
1 |
0.0008 |
| 65 |
FULL BLOOD COUNT INCREASED |
1 |
0.0008 |
| 66 |
INFUSION SITE ERYTHEMA |
7 |
0.0008 |
| 67 |
MONOCYTE COUNT DECREASED |
1 |
0.0008 |
| 68 |
RASH PRURITIC |
44 |
0.0008 |
| 69 |
BLOOD BILIRUBIN ABNORMAL |
1 |
0.0008 |
| 70 |
CATHETER SITE PAIN |
2 |
0.0008 |
| 71 |
EXFOLIATIVE RASH |
2 |
0.0008 |
| 72 |
WHITE BLOOD CELL DISORDER |
2 |
0.0007 |
| 73 |
ASPARTATE AMINOTRANSFERASE ABNORMAL |
1 |
0.0007 |
| 74 |
BODY TEMPERATURE INCREASED |
13 |
0.0006 |
| 75 |
NIGHT BLINDNESS |
1 |
0.0006 |
| 76 |
SKIN EROSION |
2 |
0.0006 |
| 77 |
TONSILLAR HYPERTROPHY |
1 |
0.0006 |
| 78 |
SEIZURE LIKE PHENOMENA |
1 |
0.0006 |
| 79 |
TONSILLITIS |
3 |
0.0006 |
| 80 |
ALANINE AMINOTRANSFERASE INCREASED |
35 |
0.0006 |
| 81 |
ASPARTATE AMINOTRANSFERASE INCREASED |
30 |
0.0006 |
| 82 |
DRUG MONITORING PROCEDURE NOT PERFORMED |
1 |
0.0006 |
| 83 |
LYMPH NODE PAIN |
1 |
0.0005 |
| 84 |
DEVICE RELATED SEPSIS |
1 |
0.0005 |
| 85 |
PLATELET COUNT ABNORMAL |
3 |
0.0005 |
| 86 |
RASH ERYTHEMATOUS |
23 |
0.0005 |
| 87 |
ALANINE AMINOTRANSFERASE ABNORMAL |
1 |
0.0005 |
| 88 |
WHITE BLOOD CELL COUNT ABNORMAL |
3 |
0.0005 |
| 89 |
INCORRECT DRUG ADMINISTRATION RATE |
2 |
0.0005 |
| 90 |
PHARYNGITIS STREPTOCOCCAL |
5 |
0.0005 |
| 91 |
HAEMATOCRIT INCREASED |
1 |
0.0004 |
| 92 |
CHILLS |
51 |
0.0004 |
| 93 |
HYPERTRANSAMINASAEMIA |
3 |
0.0004 |
| 94 |
RADIUS FRACTURE |
1 |
0.0004 |
| 95 |
RASH VESICULAR |
2 |
0.0004 |
| 96 |
HYPERGLYCAEMIA |
15 |
0.0004 |
| 97 |
VEIN DISORDER |
2 |
0.0004 |
| 98 |
FEELING COLD |
11 |
0.0004 |
| 99 |
PRODUCT PREPARATION ERROR |
8 |
0.0004 |
| 100 |
PERIORBITAL OEDEMA |
2 |
0.0004 |
| 101 |
HEPATIC ENZYME INCREASED |
26 |
0.0004 |
| 102 |
RASH |
166 |
0.0004 |
| 103 |
SHOULDER ARTHROPLASTY |
1 |
0.0004 |
| 104 |
ORAL FUNGAL INFECTION |
1 |
0.0004 |
| 105 |
NEUTROPHIL COUNT ABNORMAL |
1 |
0.0004 |
| 106 |
PYREXIA |
120 |
0.0003 |
| 107 |
VOMITING PROJECTILE |
1 |
0.0003 |
| 108 |
PULMONARY PAIN |
1 |
0.0003 |
| 109 |
EYELIDS PRURITUS |
1 |
0.0003 |
| 110 |
BRAIN FOG |
5 |
0.0003 |
| 111 |
WHITE BLOOD CELL COUNT DECREASED |
34 |
0.0003 |
| 112 |
LYMPHADENOPATHY |
11 |
0.0003 |
| 113 |
PHARYNGEAL SWELLING |
3 |
0.0003 |
| 114 |
LYMPHOCYTE COUNT INCREASED |
1 |
0.0003 |
| 115 |
PRODUCT PREPARATION ISSUE |
2 |
0.0003 |
| 116 |
TONGUE ULCERATION |
1 |
0.0003 |
| 117 |
HANGOVER |
1 |
0.0003 |
| 118 |
FIBRIN D DIMER INCREASED |
1 |
0.0003 |
| 119 |
BLOOD GLUCOSE FLUCTUATION |
3 |
0.0003 |
| 120 |
FOOD INTOLERANCE |
1 |
0.0003 |
| 121 |
SENSITIVE SKIN |
2 |
0.0003 |
| 122 |
RASH PAPULAR |
6 |
0.0003 |
| 123 |
THROAT CLEARING |
1 |
0.0003 |
| 124 |
BLOOD BILIRUBIN INCREASED |
7 |
0.0003 |
| 125 |
APHTHOUS ULCER |
2 |
0.0003 |
| 126 |
RASH MACULAR |
9 |
0.0003 |
| 127 |
FUNGAL SKIN INFECTION |
1 |
0.0002 |
| 128 |
PULSELESS ELECTRICAL ACTIVITY |
1 |
0.0002 |
| 129 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
6 |
0.0002 |
| 130 |
INFUSION SITE PAIN |
3 |
0.0002 |
| 131 |
STAPHYLOCOCCAL BACTERAEMIA |
1 |
0.0002 |
| 132 |
TRANSAMINASES INCREASED |
5 |
0.0002 |
| 133 |
RASH MACULO-PAPULAR |
5 |
0.0002 |
| 134 |
BLOOD PRESSURE SYSTOLIC DECREASED |
1 |
0.0002 |
| 135 |
INFLUENZA LIKE ILLNESS |
18 |
0.0002 |
| 136 |
SKIN TIGHTNESS |
1 |
0.0002 |
| 137 |
BLOOD GLUCOSE DECREASED |
10 |
0.0002 |
| 138 |
HEPATIC ENZYME ABNORMAL |
1 |
0.0002 |
| 139 |
NEUTROPHIL COUNT DECREASED |
8 |
0.0002 |
| 140 |
VOMITING |
92 |
0.0002 |
| 141 |
NEUTROPHIL COUNT INCREASED |
2 |
0.0002 |
| 142 |
PRODUCT TEMPERATURE EXCURSION ISSUE |
1 |
0.0002 |
| 143 |
BLOOD LACTIC ACID INCREASED |
1 |
0.0002 |
| 144 |
BEHAVIOUR DISORDER |
1 |
0.0002 |
| 145 |
LEUKOPENIA |
9 |
0.0002 |
| 146 |
STREPTOCOCCAL INFECTION |
1 |
0.0002 |
| 147 |
PERIORBITAL SWELLING |
1 |
0.0002 |
| 148 |
NAUSEA |
139 |
0.0002 |
| 149 |
FEELING OF BODY TEMPERATURE CHANGE |
1 |
0.0002 |
| 150 |
TYPE 1 DIABETES MELLITUS |
1 |
0.0002 |
| 151 |
BLOOD GLUCOSE ABNORMAL |
3 |
0.0002 |
| 152 |
INFUSION SITE EXTRAVASATION |
1 |
0.0002 |
| 153 |
SWELLING OF EYELID |
1 |
0.0002 |
| 154 |
C-REACTIVE PROTEIN ABNORMAL |
1 |
0.0002 |
| 155 |
EAR PAIN |
3 |
0.0002 |
| 156 |
FATIGUE |
119 |
0.0002 |
| 157 |
PALLOR |
4 |
0.0001 |
| 158 |
EYE MOVEMENT DISORDER |
1 |
0.0001 |
| 159 |
PAPULE |
1 |
0.0001 |
| 160 |
OROPHARYNGEAL PAIN |
13 |
0.0001 |
| 161 |
FEAR OF INJECTION |
1 |
0.0001 |
| 162 |
VISUAL FIELD DEFECT |
1 |
0.0001 |
| 163 |
HEADACHE |
86 |
0.0001 |
| 164 |
ORAL DISORDER |
1 |
0.0001 |
| 165 |
ARTHROPOD BITE |
1 |
0.0001 |
| 166 |
SUNBURN |
1 |
0.0001 |
| 167 |
INTERCEPTED PRODUCT ADMINISTRATION ERROR |
1 |
0.0001 |
| 168 |
DEVICE RELATED INFECTION |
2 |
0.0001 |
| 169 |
MUSCULOSKELETAL CHEST PAIN |
2 |
0.0001 |
| 170 |
CONCUSSION |
1 |
0.0001 |
| 171 |
APNOEA |
1 |
0.0001 |
| 172 |
PRODUCT ADMINISTRATION INTERRUPTED |
1 |
0.0001 |
| 173 |
TACHYCARDIA |
11 |
0.0001 |
| 174 |
PRESYNCOPE |
3 |
0.0001 |
| 175 |
PLATELET COUNT DECREASED |
13 |
0.0001 |
| 176 |
ESCHERICHIA INFECTION |
1 |
0.0001 |
| 177 |
UPPER-AIRWAY COUGH SYNDROME |
1 |
0.0001 |
| 178 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
3 |
0.0001 |
| 179 |
SENSATION OF FOREIGN BODY |
1 |
0.0001 |
| 180 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
2 |
0.0001 |
| 181 |
HEAD DISCOMFORT |
2 |
0.0001 |
| 182 |
MYALGIA |
19 |
0.0001 |
| 183 |
GASTROINTESTINAL INFECTION |
1 |
0.0001 |
| 184 |
JAUNDICE |
3 |
0.0001 |
| 185 |
OROPHARYNGEAL DISCOMFORT |
1 |
0.0001 |
| 186 |
LIP DRY |
1 |
0.0001 |
| 187 |
FLUSHING |
11 |
0.0001 |
| 188 |
CONJUNCTIVITIS |
2 |
0.0001 |
| 189 |
URTICARIA |
18 |
0.0001 |
| 190 |
CHEST DISCOMFORT |
11 |
0.0001 |
| 191 |
PRURITUS |
41 |
0.0001 |
| 192 |
SKIN EXFOLIATION |
9 |
0.0001 |
| 193 |
BODY TEMPERATURE DECREASED |
1 |
0.0001 |
| 194 |
HEART RATE INCREASED |
10 |
0.0001 |
| 195 |
BLOOD GLUCOSE INCREASED |
19 |
0.0001 |
| 196 |
HYPOTENSION |
20 |
0.0001 |
| 197 |
FULL BLOOD COUNT DECREASED |
2 |
0.0001 |
| 198 |
FEEDING DISORDER |
2 |
0.0001 |
| 199 |
PERIPHERAL SWELLING |
15 |
0.0001 |
| 200 |
ECZEMA |
5 |
0.0001 |
| 201 |
SCRATCH |
1 |
0.0001 |
| 202 |
FULL BLOOD COUNT ABNORMAL |
1 |
0.0001 |
| 203 |
NIGHT SWEATS |
3 |
0.0001 |
| 204 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
2 |
0.0001 |
| 205 |
SKIN LACERATION |
1 |
0.0001 |
| 206 |
PRODUCT PRESCRIBING ISSUE |
2 |
0.0001 |
| 207 |
HEPATOTOXICITY |
2 |
0.0001 |
| 208 |
GLOSSODYNIA |
2 |
0.0001 |
| 209 |
BLISTER |
5 |
0.0001 |
| 210 |
BLOOD CALCIUM DECREASED |
1 |
0.0001 |
| 211 |
DERMATITIS CONTACT |
1 |
0.0001 |
| 212 |
SPLENOMEGALY |
1 |
0.0001 |
| 213 |
DIABETIC KETOACIDOSIS |
2 |
0.0001 |
| 214 |
GENERALISED OEDEMA |
1 |
0.0001 |
| 215 |
PHARYNGITIS |
1 |
0.0001 |
| 216 |
INJECTION SITE DISCOLOURATION |
1 |
0.0001 |
| 217 |
WHITE BLOOD CELL COUNT INCREASED |
3 |
0.0001 |
| 218 |
DECREASED APPETITE |
18 |
0.0001 |
| 219 |
UNRESPONSIVE TO STIMULI |
2 |
0.0001 |
| 220 |
PLATELET COUNT INCREASED |
1 |
0.0001 |
| 221 |
BLOOD PRESSURE DECREASED |
5 |
0.0001 |
| 222 |
DEHYDRATION |
10 |
0.0001 |
| 223 |
THROAT TIGHTNESS |
2 |
0.0001 |
| 224 |
SKIN LESION |
2 |
0.0001 |
| 225 |
PERIPHERAL COLDNESS |
1 |
0.0001 |
| 226 |
NECK PAIN |
4 |
0.0001 |
| 227 |
CARPAL TUNNEL SYNDROME |
1 |
0.0001 |
| 228 |
BLOOD TEST ABNORMAL |
1 |
0.0001 |
| 229 |
DISSEMINATED INTRAVASCULAR COAGULATION |
1 |
0.0001 |
| 230 |
BRONCHOSPASM |
1 |
0.0001 |
| 231 |
RED BLOOD CELL COUNT DECREASED |
2 |
0.0001 |
| 232 |
HYPERSOMNIA |
2 |
0.0001 |
| 233 |
LETHARGY |
4 |
0.0001 |
| 234 |
LIVER FUNCTION TEST ABNORMAL |
2 |
0.0001 |
| 235 |
DYSSTASIA |
2 |
0.0001 |
| 236 |
PAIN |
42 |
0.0001 |
| 237 |
SKIN HAEMORRHAGE |
1 |
0.0001 |
| 238 |
HYPOAESTHESIA ORAL |
1 |
0.0001 |
| 239 |
FEELING HOT |
4 |
0.0001 |
| 240 |
LIMB DISCOMFORT |
2 |
0.0001 |
| 241 |
SOMNOLENCE |
13 |
0.0001 |
| 242 |
CYANOSIS |
1 |
0.0001 |
| 243 |
RESPIRATORY TRACT CONGESTION |
1 |
0.0001 |
| 244 |
SWELLING FACE |
4 |
0.0001 |
| 245 |
DRY SKIN |
8 |
0.0001 |
| 246 |
BLOOD UREA INCREASED |
1 |
0.0001 |
| 247 |
CANDIDA INFECTION |
1 |
0.0001 |
| 248 |
EOSINOPHILIA |
1 |
0.0001 |
| 249 |
HYPERKALAEMIA |
2 |
0.0001 |
| 250 |
AMENORRHOEA |
1 |
0.0001 |
| 251 |
COLD SWEAT |
1 |
0.0001 |
| 252 |
DIABETES MELLITUS INADEQUATE CONTROL |
1 |
0.0001 |
| 253 |
THIRST |
1 |
0.0001 |
| 254 |
BACK PAIN |
13 |
0.0001 |
| 255 |
CONDITION AGGRAVATED |
17 |
0.0001 |
| 256 |
CRYING |
2 |
0.0001 |
| 257 |
ACCIDENTAL OVERDOSE |
2 |
0.0001 |
| 258 |
DYSURIA |
2 |
0.0001 |
| 259 |
CHEST PAIN |
10 |
0.0001 |
| 260 |
THROMBOCYTOPENIA |
6 |
0.0001 |
| 261 |
BACTERIAL INFECTION |
1 |
0.0001 |
| 262 |
MIDDLE INSOMNIA |
1 |
0.0001 |
| 263 |
SWELLING |
5 |
0.0001 |
| 264 |
HYPOCALCAEMIA |
1 |
0.0001 |
| 265 |
DIARRHOEA |
34 |
0.0001 |
| 266 |
BLOOD PRESSURE SYSTOLIC INCREASED |
1 |
0.0001 |
| 267 |
ORAL HERPES |
1 |
0.0001 |
| 268 |
PARAESTHESIA |
8 |
0.0001 |
| 269 |
HAEMATOCRIT DECREASED |
1 |
0.0001 |
| 270 |
BLOOD PRESSURE ABNORMAL |
1 |
0.0001 |
| 271 |
DISCOMFORT |
3 |
0.0000 |
| 272 |
ABDOMINAL PAIN UPPER |
10 |
0.0000 |
| 273 |
ILLNESS |
5 |
0.0000 |
| 274 |
RETCHING |
1 |
0.0000 |
| 275 |
RHINORRHOEA |
3 |
0.0000 |
| 276 |
DEEP VEIN THROMBOSIS |
3 |
0.0000 |
| 277 |
PRODUCT DISPENSING ERROR |
1 |
0.0000 |
| 278 |
CONSTIPATION |
10 |
0.0000 |
| 279 |
BLOOD PRESSURE INCREASED |
7 |
0.0000 |
| 280 |
LIVER DISORDER |
2 |
0.0000 |
| 281 |
THROAT IRRITATION |
2 |
0.0000 |
| 282 |
CHROMATURIA |
1 |
0.0000 |
| 283 |
INCORRECT DOSE ADMINISTERED |
10 |
0.0000 |
| 284 |
ERYTHEMA |
9 |
0.0000 |
| 285 |
MALAISE |
19 |
0.0000 |
| 286 |
UPPER RESPIRATORY TRACT INFECTION |
2 |
0.0000 |
| 287 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
1 |
0.0000 |
| 288 |
BURNING SENSATION |
3 |
0.0000 |
| 289 |
MIGRAINE |
4 |
0.0000 |
| 290 |
SKIN BURNING SENSATION |
3 |
0.0000 |
| 291 |
ABDOMINAL DISCOMFORT |
7 |
0.0000 |
| 292 |
BLOOD PRESSURE FLUCTUATION |
1 |
0.0000 |
| 293 |
HYPOGLYCAEMIA |
2 |
0.0000 |
| 294 |
EPISTAXIS |
3 |
0.0000 |
| 295 |
CELLULITIS |
2 |
0.0000 |
| 296 |
ABDOMINAL PAIN LOWER |
1 |
0.0000 |
| 297 |
THERAPY CESSATION |
2 |
0.0000 |
| 298 |
HAEMOGLOBIN DECREASED |
4 |
0.0000 |
| 299 |
HYPERHIDROSIS |
5 |
0.0000 |
| 300 |
DIZZINESS |
19 |
0.0000 |
| 301 |
GASTROOESOPHAGEAL REFLUX DISEASE |
3 |
0.0000 |
| 302 |
MOOD ALTERED |
1 |
0.0000 |
| 303 |
TREMOR |
6 |
0.0000 |
| 304 |
HYPONATRAEMIA |
2 |
0.0000 |
| 305 |
PAIN IN JAW |
1 |
0.0000 |
| 306 |
FLATULENCE |
2 |
0.0000 |
| 307 |
INTENTIONAL DOSE OMISSION |
1 |
0.0000 |
| 308 |
LABORATORY TEST ABNORMAL |
1 |
0.0000 |
| 309 |
ARTHRALGIA |
14 |
0.0000 |
| 310 |
GASTROINTESTINAL DISORDER |
3 |
0.0000 |
| 311 |
NASOPHARYNGITIS |
6 |
0.0000 |
| 312 |
EMOTIONAL DISORDER |
1 |
0.0000 |
| 313 |
SWOLLEN TONGUE |
1 |
0.0000 |
| 314 |
DYSPHAGIA |
3 |
0.0000 |
| 315 |
HEAD INJURY |
1 |
0.0000 |
| 316 |
CONFUSIONAL STATE |
5 |
0.0000 |
| 317 |
INFUSION RELATED REACTION |
2 |
0.0000 |
| 318 |
THERAPEUTIC RESPONSE SHORTENED |
1 |
0.0000 |
| 319 |
VIRAL INFECTION |
1 |
0.0000 |
| 320 |
LIP SWELLING |
1 |
0.0000 |
| 321 |
SYNCOPE |
3 |
0.0000 |
| 322 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
1 |
0.0000 |
| 323 |
ASTHENIA |
11 |
0.0000 |
| 324 |
VISION BLURRED |
4 |
0.0000 |
| 325 |
RESTLESSNESS |
1 |
0.0000 |
| 326 |
INFLUENZA |
3 |
0.0000 |
| 327 |
DIABETES MELLITUS |
2 |
0.0000 |
| 328 |
ABDOMINAL PAIN |
6 |
0.0000 |
| 329 |
THROMBOSIS |
2 |
0.0000 |
| 330 |
DYSPNOEA |
14 |
0.0000 |
| 331 |
EXTRA DOSE ADMINISTERED |
1 |
0.0000 |
| 332 |
CARDIO-RESPIRATORY ARREST |
1 |
0.0000 |
| 333 |
LOSS OF CONSCIOUSNESS |
3 |
0.0000 |
| 334 |
DEVICE LEAKAGE |
1 |
0.0000 |
| 335 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
4 |
0.0000 |
| 336 |
NEUTROPENIA |
3 |
0.0000 |
| 337 |
BLOOD CHOLESTEROL INCREASED |
1 |
0.0000 |
| 338 |
COGNITIVE DISORDER |
1 |
0.0000 |
| 339 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 340 |
FEELING ABNORMAL |
5 |
0.0000 |
| 341 |
OFF LABEL USE |
18 |
0.0000 |
| 342 |
DYSPEPSIA |
2 |
0.0000 |
| 343 |
HYPOAESTHESIA |
3 |
0.0000 |
| 344 |
DRY EYE |
1 |
0.0000 |
| 345 |
FLUID RETENTION |
1 |
0.0000 |
| 346 |
INFLAMMATION |
1 |
0.0000 |
| 347 |
MUSCULOSKELETAL PAIN |
1 |
0.0000 |
| 348 |
HYPERTENSION |
4 |
0.0000 |
| 349 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 350 |
ANAPHYLACTIC REACTION |
1 |
0.0000 |
| 351 |
COUGH |
5 |
0.0000 |
| 352 |
MUSCULAR WEAKNESS |
2 |
0.0000 |
| 353 |
ANXIETY |
5 |
0.0000 |
| 354 |
HERPES ZOSTER |
1 |
0.0000 |
| 355 |
PALPITATIONS |
2 |
0.0000 |
| 356 |
BONE PAIN |
1 |
0.0000 |
| 357 |
NASAL CONGESTION |
1 |
0.0000 |
| 358 |
IRRITABILITY |
1 |
0.0000 |
| 359 |
STOMATITIS |
1 |
0.0000 |
| 360 |
OEDEMA PERIPHERAL |
2 |
0.0000 |
| 361 |
HYPERSENSITIVITY |
3 |
0.0000 |
| 362 |
AMNESIA |
1 |
0.0000 |
| 363 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 364 |
FEBRILE NEUTROPENIA |
1 |
0.0000 |
| 365 |
INSOMNIA |
4 |
0.0000 |
| 366 |
INJECTION SITE PRURITUS |
1 |
0.0000 |
| 367 |
MEMORY IMPAIRMENT |
2 |
0.0000 |
| 368 |
INJECTION SITE REACTION |
1 |
0.0000 |
| 369 |
MOBILITY DECREASED |
1 |
0.0000 |
| 370 |
UNDERDOSE |
1 |
0.0000 |
| 371 |
HOT FLUSH |
1 |
0.0000 |
| 372 |
ARTHRITIS |
1 |
0.0000 |
| 373 |
FALL |
4 |
0.0000 |
| 374 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 375 |
PAIN IN EXTREMITY |
3 |
0.0000 |
| 376 |
SEPSIS |
1 |
0.0000 |
| 377 |
ASTHMA |
1 |
0.0000 |
| 378 |
SEIZURE |
1 |
0.0000 |
| 379 |
JOINT SWELLING |
1 |
0.0000 |
| 380 |
PRODUCT USE IN UNAPPROVED INDICATION |
2 |
0.0000 |
| 381 |
INJECTION SITE ERYTHEMA |
1 |
0.0000 |
| 382 |
PRODUCT QUALITY ISSUE |
1 |
0.0000 |
| 383 |
PRODUCT DOSE OMISSION ISSUE |
2 |
0.0000 |
| 384 |
INJECTION SITE PAIN |
2 |
0.0000 |
| 385 |
PNEUMONIA |
2 |
0.0000 |
| 386 |
COVID-19 |
1 |
0.0000 |
| 387 |
NO ADVERSE EVENT |
1 |
0.0000 |
| 388 |
MUSCLE SPASMS |
1 |
0.0000 |
| 389 |
PRODUCT USE ISSUE |
1 |
0.0000 |
| 390 |
ANAEMIA |
1 |
0.0000 |
| 391 |
OVERDOSE |
1 |
0.0000 |
| 392 |
DRUG INEFFECTIVE |
4 |
0.0000 |